Undisclosed Liver Function Program

About Apterna

Apterna is a private, preclinical-stage biotech targeting advanced liver disease with novel RNA therapeutics. The company's core mission is to develop treatments that enhance liver function and regenerative capacity, thereby expanding the pool of patients eligible for curative interventions. Operating from London, it is positioned in the high-growth field of RNA medicine and targeted delivery. As a young company, its success will hinge on platform validation, pipeline progression, and securing further investment.

Therapeutic Areas